After more than a decade at Penn Medicine, cancer researcher Ronny Drapkin, MD, PhD, will join Wistar as President & CEO in November 2026.
National awards honor three Penn Medicine faculty for contributions to behavioral medicine, health policy, patient care, and scientific discovery.